0001415889-24-010960.txt : 20240417 0001415889-24-010960.hdr.sgml : 20240417 20240417161527 ACCESSION NUMBER: 0001415889-24-010960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240415 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aldag Jorn CENTRAL INDEX KEY: 0001734412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38869 FILM NUMBER: 24851254 MAIL ADDRESS: STREET 1: C/O HOOKIPA PHARMA INC. STREET 2: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 CITY: NEW YORK STATE: NY ZIP: 10118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOOKIPA Pharma Inc. CENTRAL INDEX KEY: 0001760542 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 815395687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: 0114318906360 MAIL ADDRESS: STREET 1: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 CITY: NEW YORK STATE: NY ZIP: 10118 4 1 form4-04172024_040403.xml X0508 4 2024-04-15 0001760542 HOOKIPA Pharma Inc. HOOK 0001734412 Aldag Jorn C/O HOOKIPA PHARMA INC. 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 true true false false Chief Executive Officer 0 Stock Option (Right to Buy) 0.76 2024-04-15 4 A 0 971400 0 A 2034-04-15 Common Stock 971400 971400 D 25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Reinhard Kandera, Attorney-in-Fact 2024-04-17